Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to Benzodiazepines

NCT01671410 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Neonatal Abstinence Syndrome

Interventions

DRUG: oral morphine
DRUG: sublingual buprenorphine

Sponsor

Thomas Jefferson University